David Henry's JCSO Podcast

David Henry's JCSO podcast, July 2015


 

References

In this month’s podcast for The Journal of Community and Supportive Oncology, Dr David Henry discusses a Community Translations article on lenvatinib, which was approved earlier this year for the treatment of patients with advanced differentiated thyroid cancer whose disease has progressed after radioactive iodine therapy. Also in the line-up are two Original Reports, one on health care expenditures associated with depression in adults with cancer and another on maximizing accessibility to and the efficacy of a weekly speech and language therapy service for patients with head and neck cancer who are receiving radiotherapy. A Case Report on a patient with inflammatory metastatic breast cancer with gallbladder metastases, a Feature article on new lung cancer treatments, and a summary of key findings from the 2015 annual meeting of the American Society of Clinical Oncology, round off the podcast.

Recommended Reading

Harnessing new data on immunotherapies
MDedge Hematology and Oncology
Lung cancer biomarker moves into the clinic
MDedge Hematology and Oncology
Limited resection inferior for elderly with early NSCLC
MDedge Hematology and Oncology
Solid histology predicts poor survival in resected lung adenocarcinoma
MDedge Hematology and Oncology
Immune-related patterns of response present challenges
MDedge Hematology and Oncology
Vemurafenib looks promising for several nonmelanoma malignancies
MDedge Hematology and Oncology
Lung cancer in HIV-infected patients and the role of targeted therapy
MDedge Hematology and Oncology
Treatment outcomes in stage IIIA non–small-cell lung cancer in a community cancer center
MDedge Hematology and Oncology
Genomic oncology: moving beyond the tip of the iceberg
MDedge Hematology and Oncology
Adjuvant erlotinib showed no benefit in NSCLC patients
MDedge Hematology and Oncology